Can prolonged cannabis use cause akinetic‑rigid syndrome?

Cannabis Does Not Cause Akinetic-Rigid Syndrome

Prolonged cannabis use is not associated with akinetic-rigid syndrome (parkinsonism). The available evidence, including comprehensive guidelines and research studies, does not identify akinetic-rigid syndrome as a recognized complication of cannabis use.

What Cannabis Actually Causes: Documented Neurological Effects

The most recent American College of Physicians guideline (2024) comprehensively reviews cannabis-related adverse effects and does not mention akinetic-rigid syndrome or parkinsonism 1. The documented neurological complications include:

Acute Neurological Effects

• Central nervous system depression (sedation, obtundation)
• Impaired motor coordination and reaction time affecting driving ability
• Acute toxicity symptoms: tachycardia, vomiting, myocardial ischemia in older adults 1

Chronic Neuropsychiatric Effects

• Catatonia (not parkinsonism): Recent case reports document cannabis-induced catatonia with motor symptoms including mutism, waxy flexibility, negativism, and stupor—but these are catatonic features, not parkinsonian rigidity 2, 3
• Neurological soft signs: Heavy cannabis users show motor coordination deficits and sensorimotor integration problems, but these represent functional impairments rather than akinetic-rigid syndrome 4
• Cerebrovascular complications: Stroke risk, particularly in young users 5

Critical Distinction: Catatonia vs. Akinetic-Rigid Syndrome

Do not confuse cannabis-induced catatonia with parkinsonism. While both can present with reduced movement:

• Catatonia features: mutism, waxy flexibility, negativism, stupor, thought blocking 2, 3
• Akinetic-rigid syndrome features: bradykinesia, cogwheel rigidity, resting tremor, postural instability

Cannabis-induced catatonia is documented and can be severe, requiring lorazepam and ECT 2, 3. This is fundamentally different from the dopaminergic dysfunction underlying parkinsonism.

Paradoxical Therapeutic Use in Movement Disorders

Interestingly, cannabis-based medicines are actually used to treat certain movement disorders, not cause them:

• THC-containing products improve tics in Tourette syndrome 6
• May improve tremor and non-motor symptoms in Parkinson's disease 6
• Used for spasticity in multiple sclerosis and stiff-person syndrome 7, 6

This therapeutic profile is incompatible with cannabis causing akinetic-rigid syndrome.

Clinical Pitfall to Avoid

If a cannabis user presents with apparent rigidity or reduced movement, systematically evaluate for:

1. Cannabis-induced catatonia (check for waxy flexibility, negativism, mutism)
2. Concurrent antipsychotic use (neuroleptic-induced parkinsonism is common in this population)
3. Primary psychiatric disorders with catatonic features
4. Cerebrovascular events (cannabis increases stroke risk) 5
5. Other substance use or withdrawal states

The evidence does not support cannabis as a direct cause of akinetic-rigid syndrome affecting morbidity or mortality through parkinsonian mechanisms.